Clinical Trials Directory

Trials / Completed

CompletedNCT04017039

Sleep, Blood Pressure and Vascular Health

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
107 (actual)
Sponsor
University of Colorado, Boulder · Academic / Other
Sex
All
Age
45 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesize that chronic insufficient sleep is associated with diminished endothelium-dependent nitric oxide-mediated vasodilation and endothelial tissue-type plasminogen activator release in adults with elevated blood pressure. Furthermore, the investigators hypothesize that the postulated diminishment in endothelial vasodilator and fibrinolytic function with insufficient sleep will be due, at least in part, to increased oxidative stress. Furthermore, increasing sleep duration and improving sleep quality will increase both endothelium-dependent nitric oxide-mediated vasodilation and endothelial tissue-type plasminogen activator release in adults with elevated blood pressure. Increases in endothelial vasodilator and fibrinolytic function will be due, at least in part, to reduced oxidative stress.

Conditions

Interventions

TypeNameDescription
OTHERTargeted Sleep Intervention

Timeline

Start date
2016-11-10
Primary completion
2021-11-01
Completion
2023-05-01
First posted
2019-07-12
Last updated
2023-11-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04017039. Inclusion in this directory is not an endorsement.